Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Ku saabsan shirkaddayadaDulmar Guud oo ku saabsan Daaweynta CAR-T

Daaweynta CAR-T, oo loo soo gaabiyo Chimeric Antigen Receptor T-Cell Immunotherapy, waa hab daaweyn hidde-side oo horumarsan oo ku lug leh wax ka beddelka hidde-sideyaasha unugyada T ee bukaanka si loo bartilmaameedsado loona burburiyo unugyada kansarka. Si ka duwan daawooyinka dhaqameed, daaweynta CAR-T waxaa loogu talagalay bukaan kasta waxayna u baahan tahay in unugyada T laga soo ururiyo dhiigga bukaanka ka hor inta aan dib loogu shubin jirka ka dib injineernimada hidde-sidaha.
DULUCDA DAAWEYNTA CAR-T (1)smn
Sahaminta Astaamaha

Tilmaamaha CAR-T

● Leukemia-da lymphoblastic ee ba'an ee unugyada B-cell

● Myeloma badan

● Leukemia-da lymphocytic ee daba-dheeraatay

● Lymphoma-ka aan ahayn Hodgkin

● Kala-goysyada waaweyn ee unugyada B-cell oo faafa

● SLE (Lupus Erythematosus oo nidaamsan)

Waxqabad caafimaad oo heer sare ah oo CAR-T ah

Tilmaamaha CD19+20CAR-T: Bukaannada qaba lymphoma-ka aan ahayn Hodgkin ee unugyada B

Heerka CR ee hal bil ah

Heerka PR ee hal bil

Hal bil AMA qiime

CRS≥3

CRES≥3

71.95%(59/82)

25.6(21/82)

97.55(80/82)

12.19%(10/82)

0

Tilmaamaha CD19+22CAR-T: Daaweynta bukaanada qaba cudurka 'B-lymphocytic leukemia' ee CD19 oo dib u soo noq noqday iyo kuwa aan firfircoonayn

Heerka CR ee hal bil ah

Heerka PR ee hal bil

Hal bil AMA qiime

CRS≥3

CRES≥3

92.1%(35/38)

7.9%(3/38)

100% (38/38)

15.79%(6/38)

0

Tilmaamaha loogu talagalay BCMACAR-T: Daaweynta myeloma badan oo soo noqnoqota iyo mid aan firfircoonayn

Heerka CR ee hal bil ah

Heerka PR ee hal bil

Hal bil AMA qiime

CRS≥3

CRES≥3

72.41%(21/29)

27.59%(8/29)

100% (29/29)

6.9%(2/29)

0

DULUCDA DAAWEYNTA BAABUR-T (2)6u3

Maxaad Noo Dooranaysaa?

Faa'iidooyinkayaga

Daaweynta Shakhsi ahaaneed: Waxaan u habeyneynaa daaweynta CAR-T bukaan kasta, annagoo hubinayna daaweyn bartilmaameedsan oo wax ku ool ah.

Xulashooyinka Bartilmaameedka Kala Duwan: Badeecadahayaga CAR-T waxay bixiyaan xulashooyin badan oo bartilmaameed ah, oo ay ku jiraan CD7, CD19, CD20, CD22, iyo BCMA, iyagoo bixinaya faa'iidada ikhtiyaarrada daaweynta ee shakhsi ahaaneed ee bukaanada.

Tiknoolajiyadda Casriga ah: Daawayntayada CAR-T waxay isticmaashaa horumarkii ugu dambeeyay ee injineernimada hidde-sidaha iyo daaweynta difaaca jirka.

Waxtarka kharash-oolnimada sare: Marka la barbardhigo alaabada kale, waxaan bixinaa isku dheelitirnaan heer sare ah oo u dhaxaysa hubinta tayada iyo qiimaha tartanka.

Khibrad Caafimaad: Iyadoo ay taageerayaan koox dhakhaatiir khibrad leh iyo cilmi-baarayaal ah, waxaanu bixinaa daryeel iyo taageero tayo sare leh inta lagu jiro habka daaweynta.

Hab Dhammaystiran: Waxaan bixinaa daryeel dhammaystiran, laga bilaabo qiimaynta bukaanka ilaa maamulka daaweynta iyo dabagalka, iyadoo la hubinayo natiijooyinka ugu wanaagsan.